ImmuCell Corp

Insider buying at ImmuCell signals bullish confidence—Kathy Turner and peers are buying shares as the stock climbs, offering a potential upside for investors.

Insider option activity at ImmuCell shows confidence in its rising biotech focus—free‑cost exercises suggest insiders see undervalued upside, potentially boosting future share performance.